[DOI] [PubMed] [Google Scholar] 1124.Hill G.W., Morest D.K., Parham K
Current data shows 40% of US adults live with obesity, more than 100 million potential users, yet demand for these medications remains high despite substantial costs
RC: Yes, weight loss plateaus are completely normal and expected on GLP-1 medications, and weight loss is rarely linear
[12] [13] If you experience any suspected side effects, you can report them via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
I wouldnt recommend semaglutide for AUD in isolation, but if a patient meets BMI or blood sugar criteria for use, and over-drinking is an issue, its a win-win medication, she said
Hispanics had the second fastest increase, with a slope of 54.15 and an R 2 of 0.98